Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Past hour
    • Any time
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

The Lancet10h
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial
Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

DOJ reaches deal w/ Boeing
Diagnosed w/ brain disorder
Caught up in Trump's fight
Kyiv hit by major attack
Iconic photographer dies
'Rust' armorer released
To close CosMc’s locations
Agrees to plead guilty
Jones' husband dies
Crypto investor arrested
White House trims NSC staff
Convicted of manslaughter
Inmate escapes for 2nd time
To partner with US Steel
Judge blocks Trump order
Sanctions relief for Syria
Super vision contact lenses?
Leaves game with injury
SoCal Edison to pay $82.5M
Hamburg stabbing
Sues 4 New Jersey cities
Signs nuclear energy orders
New home sales rise
Trump threatens 25% tariff
Allows to shield DOGE docs
Record floodwaters in AU
South Africa mine rescue
Violated civil rights law?
Signs bill to protect parks
8 found guilty in robbery
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy